About David Weitz
Form D filings for Syrna Therapeutics in 2023 list David Weitz as chief executive officer and director.
David Weitz first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David Weitz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Weitz works with at each company, as listed on that company's latest Form D.
Syrna Therapeutics, Inc. · Form D, Aug 10, 2023